Afisarea articolelor 1-3(3) pentru cuvîntul-cheie "
CGRP"
Effects of Anti-CGRP monoclonal antibodies for episodic and chronic migraineon migraine characteristics, disability, impact and quality of life beyond 3 months of treatment: A Systematic review and Meta-analysis |
Grosu Oxana1, Yamani Nooshin2, Schuster Nathaniel3, Sreedharan Jayadevan4, Berchan Joelle5, Pradeep Manu6, Riahi Anis7, Thomas Pravin89 |
1 Diomid Gherman Institute of Neurology and Neurosurgery, 2 Zanjan University of Medical Sciences, Zanjan, 3 UC San Diego Center for Pain Medicine, 4 Gulf Medical University, 5 Lebanese University, Beirut, Lebanon, 6 Amrita School of Medicine, Kerala, 7 Military Hospital of Tunis, 8 World Headache Society, 9 UCL Queen Square Institute of Neurology |
Headache Medicine Connections |
Nr. 2(1) / 2021 / ISSN 2754-2580 |
Disponibil online 18 November, 2022. Descarcări-2. Vizualizări-345 |
----------------------------------------------------------------------------------------------------------------------------------- Debate: differences and similarities between tension-type headache and migraine |
Onan Dilara1, Younis Samaira2, Wellsgatnik William David3, Farham Fatemeh4, Andruskevicius Saulius5, Abashidze Ana6, Jusupova Asel7, Romanenko Yuriy8, Grosu Oxana9, Moldokulova Meerimgul7, Mursalova Ulkar10, Saidkhodjaeva Saida N.11, Martelletti Paolo3, Ashina Sait1213 |
2 Danish Headache Center, The University of Copenhagen, 3 Sapienza University of Rome, 5 Vilnius University, 6 Caucasus Medical Centre, Tbilisi, 7 Kyrgyz State Medical Academy named after I.K. Akhunbaev, Bishkek, 8 Medical Center “Medical Ventera Group”, Kyiv, 9 Diomid Gherman Institute of Neurology and Neurosurgery, 10 Republican Perinatal Center, Baku, 11 Tashkent Pediatric Medical Institute, 12 Harvard Medical School, Boston, 13 University of Copenhagen |
Journal of Headache and Pain |
Nr. / 2023 / ISSN 1129-2369 /ISSNe 1129-2377 |
Disponibil online 15 August, 2023. Descarcări-4. Vizualizări-179 |
----------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------
1-3 of 3